Scrip's Five Must-Know Things - September 5, 2025
Update: 2025-09-08
Description
Audio roundup of selected biopharma industry content from Scrip over the business week ended September 5, 2025. In this episode: the US MASH market after Wegovy’s approval; AstraZeneca and Mineralys in close hypertension race; United Therapeutics’ Phase III win in IPF; Corsera aims to predict and prevent cardiovascular disease; and Ionis’s RNA-targeted win in severe hypertriglyceridemia.
https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-RKP4E4CFGFGGXBRVXTI73V27U4/
This episode was produced with the help of AI text-to-voice and voice emulation tools.
Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-RKP4E4CFGFGGXBRVXTI73V27U4/
This episode was produced with the help of AI text-to-voice and voice emulation tools.
Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
